Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma

키워드

참고문헌 (72)

1. 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015", Cancer Research and Treatment, 50(2), pp.303~316 (2018), 대한암학회
2. Perz JF, "The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide", J Hepatol, 45, pp.529~538 (2006)
3. Ock M, "Trend analysis of major cancer statis tics according to sex and severity levels in Korea", PLoS One, 13, pp.e0203110~ (2018)
4. European Association for the Study of the Liver, "EASL clinical practice guidelines: management of hepatocellular carcinoma", J Hepatol, 69, pp.182~236 (2018)
5. Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC, "2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma", Gut and Liver, 13(3), pp.227~299 (2019), 거트앤리버 소화기연관학회협의회[DOI]
6. Delis SG, "Selection criteria for liver resection in patients with hepatocellular carcinoma and chronic liver disease", World J Gastroenterol, 14, pp.3452~3460 (2008)
7. Tiong L, "Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma", Br J Surg, 98, pp.1210~1224 (2011)
8. Benedict SH, "Stereotactic body radiation therapy: the report of AAPM Task Group 101", Med Phys, 37, pp.4078~4101 (2010)
9. Rim CH, "Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: a systematic review and meta-analysis of observational studies", Radiother Oncol, 131, pp.135~144 (2019)
10. Vogel A, "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up", Ann Oncol, 29(Suppl 4), pp.iv238~iv255 (2018)
11. Murray LJ, "Advances in stereotactic body radiation therapy for hepatocellular carcinoma", Semin Radiat Oncol, 27, pp.247~255 (2017)
12. Yoon SM, "Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma", PLoS One, 8, pp.e79854~ (2013)
13. Sanuki N, "Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients", Acta Oncol, 53, pp.399~404 (2014)
14. Sanuki N, "Role of stereotactic body radiation therapy for hepatocellular carcinoma", World J Gastroenterol, 20, pp.3100~3111 (2014)
15. Dawson LA, "The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy", Int J Radiat Oncol Biol Phys, 51, pp.1410~1421 (2001)
16. Herfarth KK, "Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases", Int J Radiat Oncol Biol Phys, 46, pp.329~335 (2000)
17. Brock KK, "Imaging and image-guided radiation therapy in liver cancer", Semin Radiat Oncol, 21, pp.247~255 (2011)
18. Park SH, "Technical advances in external radiotherapy for hepatocellular carcinoma", World J Gastroenterol, 22, pp.7311~7321 (2016)
19. Scorsetti M, "The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT)", J Cancer Res Clin Oncol, 141, pp.1301~1309 (2015)
20. 이경화, "Is higher dose always the right answer in stereotactic body radiation therapy for small hepatocellular carcinoma?", Radiation oncology journal, 36(2), pp.129~138 (2018), 대한방사선종양학회
21. Jang WI, "High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma", Radiat Oncol, 8, pp.250~ (2013)
22. Mizumoto M, "Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols", Int J Radiat Oncol Biol Phys, 81, pp.1039~1045 (2011)
23. Kasuya G, "Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: combined analyses of 2 prospective trials", Cancer, 123, pp.3955~3965 (2017)
24. Toramatsu C, "What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy", Radiat Oncol, 8, pp.48~ (2013)
25. Gandhi SJ, "Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: Photons versus protons", Pract Radiat Oncol, 5, pp.209~218 (2015)
26. Blomgren H, "Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients", Acta Oncol, 34, pp.861~870 (1995)
27. Shiozawa K, "Comparison of percutaneous radiofrequency ablation and CyberKnife® for initial solitary hepatocellular carcinoma: A pilot study", World J Gastroenterol, 21, pp.13490~13499 (2015)
28. Wahl DR, "Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma", J Clin Oncol, 34, pp.452~459 (2016)
29. Bujold A, "Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma", J Clin Oncol, 31, pp.1631~1639 (2013)
30. Rhim H, "Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings", Radiographics, 23, pp.123~134 (2003)
31. Rice SL, "The management of colorectal cancer liver metastases: the interventional radiology viewpoint", Int J Radiat Oncol Biol Phys, 103, pp.537~539 (2019)
32. Lee S, "Evaluation of hepatic toxicity after repeated stereotactic body radiation therapy for recurrent hepatocellular carcinoma using deformable image registration", Sci Rep, 8, pp.16224~ (2018)
33. Rajyaguru DJ, "Radiofrequency ablation versus stereotactic body radiotherapy for localized hepatocellular carcinoma in nonsurgically managed patients: analysis of the national cancer database", J Clin Oncol, 36, pp.600~608 (2018)
34. Nakano R, "Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: a propensity-matched analysis in a single institution", Surgery, 164, pp.219~226 (2018)
35. Su TS, "Long-term survival analysis of stereotactic ablative radiotherapy versus liver resection for small hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 98, pp.639~646 (2017)
36. Pan CC, "Radiation-associated liver injury", Int J Radiat Oncol Biol Phys, 76(3 Suppl), pp.S94~S100 (2010)
37. Liang SX, "Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance", Int J Radiat Oncol Biol Phys, 65, pp.426~434 (2006)
38. Jung J, "Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters", Radiat Oncol, 8, pp.249~ (2013)
39. Culleton S, "Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma", Radiother Oncol, 111, pp.412~417 (2014)
40. Su TS, "Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients", J Surg Oncol, 113, pp.181~187 (2016)
41. Dawson LA, "Overview: where does radiation therapy fit in the spectrum of liver cancer local-regional therapies?", Semin Radiat Oncol, 21, pp.241~246 (2011)
42. Kavanagh BD, "Radiation dose-volume effects in the stomach and small bowel", Int J Radiat Oncol Biol Phys, 76(3 Suppl), pp.S101~S107 (2010)
43. Bae SH, "Severe intestinal toxicity after stereotactic ablative radiotherapy for abdominopelvic malignancies", Int J Colorectal Dis, 28, pp.1707~1713 (2013)
44. LaCouture TA, "Small bowel dose tolerance for stereotactic body radiation therapy", Semin Radiat Oncol, 26, pp.157~164 (2016)
45. Goldsmith C, "Dose-volume histogram analysis of stereotactic body radiotherapy treatment of pancreatic cancer: a focus on duodenal dose constraints", Semin Radiat Oncol, 26, pp.149~156 (2016)
46. Yamashita H, "Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma", J Radiat Res, 56, pp.561~567 (2015)
47. Sapir E, "Stereotactic body radiation therapy as an alternative to transarterial chemoembolization for hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 100, pp.122~130 (2018)
48. Jeong Y, "Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma", BMC Cancer, 18, pp.416~ (2018)
49. Eriguchi T, "Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system", Int J Radiat Oncol Biol Phys, 85, pp.1006~1011 (2013)
50. Toesca DA, "Central liver toxicity after SBRT: an expanded analysis and predictive nomogram", Radiother Oncol, 122, pp.130~136 (2017)
51. O’Connor JK, "Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation", Liver Transpl, 18, pp.949~954 (2012)
52. Andolino DL, "Stereotactic body radiotherapy for primary hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 81, pp.e447~e453 (2011)
53. Sapisochin G, "Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis", J Hepatol, 67, pp.92~99 (2017)
54. Mohamed M, "Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma", Adv Radiat Oncol, 1, pp.35~42 (2015)
55. Kim JY, "Hepatocellular carcinoma with portal vein tumor thrombosis: Improved treatment outcomes with external beam radiation therapy", Hepatol Res, 41, pp.813~824 (2011)
56. Im JH, "Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area", Liver Int, 37, pp.90~100 (2017)
57. 배선현, "Multicenter Planning Comparison of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis (KROG 16-17)", Journal of Liver Cancer, 18(2), pp.130~141 (2018), 대한간암학회[DOI]
58. Xi M, "Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and", or inferior vena cava tumor thrombosis, 2013, pp.8, e63864~
59. Kang J, "Stereotactic body radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis", Mol Clin Oncol, 2, pp.43~50 (2014)
60. Shui Y, "Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis", Radiat Oncol, 13, pp.188~ (2018)
61. Meng MB, "Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis", Radiother Oncol, 92, pp.184~194 (2009)
62. Jacob R, "Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥3 cm", HPB (Oxford), 17, pp.140~149 (2015)
63. Paik EK, "Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma", Radiat Oncol, 11, pp.22~ (2016)
64. Llovet JM, "Sorafenib in advanced hepatocellular carcinoma", N Engl J Med, 359, pp.378~390 (2008)
65. Yu W, "Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo", Cancer Lett, 329, pp.109~117 (2013)
66. Barney BM, "Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT)", Int J Radiat Oncol Biol Phys, 87, pp.73~80 (2013)
67. Brade AM, "Phase 1 trial of sorafenib and stereotactic body radiation therapy for hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 94, pp.580~587 (2016)
68. Kang J, "Current clinical trials testing the combination of immunotherapy with radiotherapy", J Immunother Cancer, 4, pp.51~ (2016)
69. Bernstein MB, "Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?", Nat Rev Clin Oncol, 13, pp.516~524 (2016)
70. Formenti SC, "Optimizing dose per fraction: a new chapter in the story of the abscopal effect?", Int J Radiat Oncol Biol Phys, 99, pp.677~679 (2017)
71. Vanpouille-Box C, "Toward precision radiotherapy for use with immune checkpoint blockers", Clin Cancer Res, 24, pp.259~265 (2018)
72. Kim KJ, "Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model", Oncotarget, 8, pp.41242~41255 (2017)

관련 논문AI추천